GaMF1.39

• Description :

  GaMF1.39 is an antimycobacterial compound, targeting the F-ATP synthase subunit γ. GaMF1.39 displays enhanced anti-tuberculosis activity in combination with ETC inhibitors[1].

• UNSPSC :

  12352005

• Target :

  Bacterial

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/gamf1-39.html

• Solubility :

  10 mM in DMSO

• Smiles :

  ClC1=CC=C(C2=NC3=C(C=CC(NC4=NC(NCC)=CC(C)=N4)=C3)N2)C=C1

• Molecular Formula :

  C20H19ClN6

• Molecular Weight :

  378.86

• References & Citations :

  [1]Ragunathan P, et al. GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876. Microbiol Spectr. 2023;11 (6) :e0228223.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2568607-82-7]